Terns Pharmaceuticals Inc (TERN) concluded trading on Wednesday at a closing price of $7.08, with 4.72 million shares of worth about $33.41 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 3.06% during that period and on December 04, 2024 the price saw a gain of about 11.32%. Currently the company’s common shares owned by public are about 84.92M shares, out of which, 62.16M shares are available for trading.
Stock saw a price change of 20.41% in past 5 days and over the past one month there was a price change of -0.28%. Year-to-date (YTD), TERN shares are showing a performance of 9.09% which increased to 16.64% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.32 but also hit the highest price of $11.40 during that period. The average intraday trading volume for Terns Pharmaceuticals Inc shares is 2.10 million. The stock is currently trading 10.38% above its 20-day simple moving average (SMA20), while that difference is down -0.54% for SMA50 and it goes to -0.45% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Terns Pharmaceuticals Inc (NASDAQ: TERN) currently have 84.92M outstanding shares and institutions hold larger chunk of about 71.59% of that.
The stock has a current market capitalization of $601.37M and its 3Y-monthly beta is at -0.37. It has posted earnings per share of -$1.18 in the same period. It has Quick Ratio of 32.99 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TERN, volatility over the week remained 9.02% while standing at 7.22% over the month.
Stock’s fiscal year EPS is expected to rise by 5.73% while it is estimated to decrease by -11.48% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Oppenheimer on October 31, 2024 offering an Outperform rating for the stock and assigned a target price of $82 to it. Coverage by Mizuho stated Terns Pharmaceuticals Inc (TERN) stock as a Buy in their note to investors on June 22, 2023, suggesting a price target of $16 for the stock. On June 07, 2023, Jefferies Initiated their recommendations, while on May 31, 2023, ROTH MKM Initiated their ratings for the stock with a price target of $23. Stock get an Outperform rating from BMO Capital Markets on May 08, 2023.
